Skip to main content
56th ASAM Annual Conference Main banner
Final Program


Preview Program
Back

Workshop Session

Concurrent Sessions #4

Injectable Medications for Addiction: Hands-On Practice for Providers
Room Capacity Limited to 150

Friday, April 25, 2025
3:00 PM – 4:15 PM  
Every patient is different and needs a personalized approach to care. Access to all treatment options ensures that each person can receive the most appropriate and effective care for their unique needs. It is important that healthcare professionals understand the full range of available interventions so they can tailor treatments to suit each person's specific circumstances. One effective, but often misunderstood and underutilized treatment option is LAI medications.

Each training session will begin with a concise 10–15 minute didactic presentation covering the fundamentals of injectable medication administration and key clinical considerations. This will be followed by a 60-minute hands-on practice session in small groups, rotating through skill-building stations. Each station will be equipped with anatomical models, essential injection supplies (e.g., sharps containers, gloves), and guided by experienced facilitators. Participants will receive step-by-step instruction, hands-on support in identifying anatomical landmarks for injection sites, and real-time feedback on intramuscular and subcutaneous injection techniques to ensure safe and effective administration. Each session is limited to 100 participants.
Disclosure(s):
Megan Ehret, PharmD, MS, BCPP, FAAPP: No financial relationships to disclose
Jaden Dickinson, PharmD, BCPP: AbbVie: Husband is an MSL for Vraylar. He has stock as their employee. (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)
Hannah Wilkoff, PharmD, BCPP: No financial relationships to disclose
Vincent S. Cavaliere, PharmD, MM, BCPP: No financial relationships to disclose
Mark Bickley, PharmD, BCPP: No financial relationships to disclose